Breaking News
Get 50% Off 0
Get a powerful boost to your portfolio: August's freshest AI-picked stocks
Pick Stocks with AI
Close

Tempo Scan Pacific Tbk (TSPC)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2,200 -10    -0.45%
10:39:59 - Closed. Currency in IDR
Type:  Equity
Market:  Indonesia
ISIN:  ID1000104508 
  • Volume: 2,631,400
  • Bid/Ask: 2,200 / 2,210
  • Day's Range: 2,200 - 2,240
Tempo Scan Pacific 2,200 -10 -0.45%

Tempo Scan Pacific Tbk Company Profile

 
Get an in-depth profile of Tempo Scan Pacific Tbk, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

4480

Equity Type

ORD

PT Tempo Scan Pacific Tbk engages in the pharmaceuticals, personal care and cosmetics, and distribution services businesses in Indonesia and internationally. The company operates through Pharmaceuticals, Consumer Products and Cosmetics, and Distribution Services segments. It is involved in the pharmaceutical and medical devices trading; manufacture of soaps, herbal products, powder milk, food and beverages, and plastic packaging; and manufacturing and trading of consumer products, cosmetics, and household products. The company sells its products under the Bodrex, Oskadon, Neo rheumacyl, Bodrexin, Contrexyn, Contrex, Oskadryl, Vidoran, Neodulax, Vidoran, Hemaviton, Neo Hormoviton, Polaris, Vitonal, Vitamin IPI, Neo rheumacyl Herbal, Wybert Herbal, Bodrexin Herbal, Herbalax, Marina, Natural Honey, Claudia, Total Care, and ULTIMA II brands. It also engages in the construction and rental of buildings; provision of warehousing, advertising and promotion, research and development, and information technology and communication network systems services; and procurement, distribution, and marketing activities. The company was formerly known as PT Scanchemie. PT Tempo Scan Pacific Tbk was founded in 1970 and is based in Jakarta, Indonesia. The company operates as a subsidiary of PT Bogamulia Nagadi.

Contact Information

Address Tempo Scan Tower 16th Floor
Jl. H.R. Rasuna Said, Kav. 3-4 Jakarta,12950
Indonesia
Phone 62 21 2921 8888
Fax 62 21 2920 9999

Top Executives

Name Age Since Title
Handojo Selamet Muljadi 57 1987 President Commissioner
Diana Wirawan 66 1990 Vice President Director
Liza Prasodjo 52 2012 Vice President Director
I Made Dharma Wijaya 52 2018 President Director and MD of Sales & Operation - Distribution Division
- Shania 48 2017 Group General Counsel Director, Corporate Secretary & Director
Linda Lukitasari 57 2015 Research & Development Director and Director
Agus Sutomo 64 2024 Independent Commissioner
Aviaska Diah Respati Herlambang 59 2023 Director
Suparni Parto Setiono 69 2016 Independent Commissioner
Rorita Lim 48 2019 Director
. Kustantinah 74 2012 Independent Commissioner
Hartaty Susanto 65 2012 Commissioner
Ruth Dewi Rosila Widjaja 56 2024 Director
Ernes Beneldy - 2024 Director
Josep Ismanto 54 2022 Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

TSPC Comments

Write your thoughts about Tempo Scan Pacific Tbk
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email